Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version)
Mil. med. res. (Lond.); 7 (41), 2020
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness,
coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis
and treatment guidelines for clinicians caring for patients are needed. In the ...
Quimioprevención/métodos, Infecciones por Coronavirus/diagnóstico, Infecciones por Coronavirus/tratamiento farmacológico, Neumonía Viral/diagnóstico, Neumonía Viral/tratamiento farmacológico, Pandemias/prevención & control, Betacoronavirus/efectos de los fármacos, Práctica Clínica Basada en la Evidencia/métodos, Antirretrovirales/uso terapéutico, Lopinavir/uso terapéutico, Cloroquina/uso terapéutico, Receptores de Interleucina-6/uso terapéutico, Hidroxicloroquina/uso terapéutico, Plasma/inmunología